International Pharmaceutical Regulatory Monitor

June 2012 | Vol. 40 No. 6

EMA Updates Guideline on Clinical Investigations of VTE Products

The European Medicines Agency (EMA) has updated its draft guideline on clinical investigations of venous thromboembolism (VTE) products, adding new definitions for bleeding events and secondary endpoints to consider for clinical trials.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

FDA to Hold Two-Day Public Meeting on REMS Challenges Lawmakers Say Gluten Should Be Noted On Drug Labels Ranbaxy Settles cGMP Case With Dept. of Justice FDA to Focus on HIV in Next Patient-Focused Drug Development Meeting

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.